HNF4A and COVID-19: These results corroborate the role of HNF-4α in COVID-19 and other chronic lung pathologies (Agudelo et al., 2020; Nardacci et al., 2021), potentially through its role as a master regulator of lipid metabolism, but only for the G2 group.